$ACCO

ACCO (ACCO) Q2 2026 Earnings Call Transcript

ACCO Brands (ACCO) reported Q2 2026 net sales of $415.1 million, up 5.1% on the EPOS acquisition and FX, while comparable sales fell 2.3%. Adjusted diluted EPS rose to $0.29. Management raised full-year net sales growth to 2% to 5% and adjusted EPS to $0.87 to $0.91, citing cost savings and EPOS integration. Q3 sales guidance is -1% to +2%.

Original reporting
Published Aug 8, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 4:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ACCO (ACCO) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ACCOBullishMed
01

Why it matters

Management raised full-year sales and adjusted EPS guidance, reiterated cost savings progress, and provided leverage and free cash flow targets. However, Q3 sales and EPS guidance were tempered by adverse product and geographic mix and higher inflationary costs.

02

Market read

Traders can update earnings expectations using the raised FY net sales and adjusted EPS ranges, plus the explicit Q3 sales and EPS guidance ranges and margin headwind framing.

03

What to watch

Tariff refund claims timing (Phase 2 submissions) and the pace of EPOS cost synergies (expected $15M within 18 months) could be key swing factors for cash flow and margin durability.

Relevance 9/10Novelty 8/10Timing: pre-market today, following the Q2 2026 earnings call and updated FY/Q3 guidance

Background

ACCO Brands reported Q2 2026 results and discussed EPOS acquisition integration alongside a multiyear cost reduction program.

Company-level read

Ticker impact

$ACCOBullishMedium confidence
Context

ACCO raised full-year net sales guidance to 2% to 5% and lifted adjusted EPS to $0.87 to $0.91 after Q2 results and EPOS integration progress.

Expected impact

Likely supportive for the stock versus prior guidance, with follow-through dependent on whether Q3 mix and margin headwinds materialize.

Evidence & confidence

The article provides specific, time-bound guidance changes (FY sales/EPS, leverage ratio, FCF) plus a lower Q3 sales range and adverse mix assumption, which should drive incremental repricing around earnings expectations.

Market effects

Signals resilience in accessory/technology-peripheral demand via back-to-school sell-in and acquisition-driven growth, despite weaker PC shipment backdrop.

Americas strength (back-to-school, Mexico) contrasted with weaker International demand tied to geopolitical and economic conditions.

Highlights how FX and tariff-related items (refund claims) can swing margins and cash flow for consumer hardware-adjacent distributors.

Counterpoint

Raised FY guidance may be offset by Q3 gross margin and operating income pressure from inflation and pricing lag, making the stock vulnerable if margins disappoint.

Key entities

  • ACCO Brands Corporation

    Reported Q2 2026 net sales of $415.1M, raised FY guidance, and guided Q3 with cautious mix and margin assumptions.

  • EPOS

    Integration progress contributed $22.4M of Q2 sales and is expected to deliver $15M cost synergies within 18 months.

  • Thomas Tedford

    CEO who discussed demand softness, pricing lag versus cost inflation, and expectations for category momentum.

  • Deb O'Connor

    CFO who outlined margin headwinds from inflation and provided leverage and cash flow guidance.

Related articles

$ACCOMed

ACCO BRANDS Corp (ACCO): Results of Operations and Financial Condition

ACCO BRANDS Corp (ACCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 acco-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release ACCO BRANDS REPORTS SECOND QUARTER RESULTS • Reported net sales increased 5.1% to $415 million • Diluted EPS of $0.15; Adjusted diluted EPS of $0.29 • Raises full-year 2026 sales and adjusted EPS outlook • Reiter

$HRMedAI 8/10

Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust (HR) reported Q2 2026 normalized FFO of $0.41/share and same-store cash NOI growth of 5.1% y/y. It raised normalized FFO guidance to $1.62 to $1.66/share and same-store cash NOI growth guidance to 4.3% to 5.0%. GAAP net loss was $0.13/share after $42.7m impairments. HR also discussed $200m JV acquisitions, $83m asset dispositions, and $75m Q2 repurchases.

$PSOMedAI 8/10

Pearson (PSO) Q2 2026 Earnings Call Transcript

Pearson (PSO) reported H1 2026 adjusted operating profit of £226m, up 14%, and adjusted EPS of 28.9p, up 19% at constant exchange rates. Adjusted operating margin rose to 15.5%. Free cash flow was £259m. Full-year guidance calls for adjusted operating profit of £640m to £685m and mid-single-digit revenue growth.

$IRMDMedAI 9/10

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

IRadimed (IRMD) reported Q2 2026 revenue of $20.5 million, up 0.5% from $20.4 million a year earlier. GAAP diluted EPS was $0.41 versus $0.45, and non-GAAP EPS was $0.46. Gross margin fell to 74% from 78% due to higher manufacturing costs during the 3870 pump ramp. Q3 revenue guidance is $23.0 to $24.5 million; full-year 2026 revenue guidance is $91 to $96 million.

$CRIMedAI 8/10

Carter's (CRI) Q2 2026 Earnings Call Transcript

Carter’s (CRI) reported Q2 FY2026 net sales of $615.5 million, up 5.2%, with adjusted operating income of $18.1 million and adjusted diluted EPS of $0.26. U.S. retail comp sales rose 5.1%. The company recovered $132 million from tariff-related duties and revised FY2026 net sales guidance to 2% to 3% growth.

$TUHighAI 9/10

TELUS (TU) Q2 2026 Earnings Call Transcript

TELUS (TU) reported Q2 2026 results: service revenue C$4.4B (-1% YoY), adjusted EBITDA C$1.8B (-2%), adjusted EPS C$0.16, and free cash flow C$545M (+2%). The company cut its dividend to C$0.1875/share (-55%), targets net debt/EBITDA of 3x by end-2028, and recorded a C$2.1B TELUS Digital impairment. 2026 guidance was revised lower.